Kazuyoshi Takeda Selected Research

Kazuyoshi Takeda Research Topics

Disease

80	Neoplasms (Cancer) 01/2022 - 01/2002
25	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2002
8	Testicular Neoplasms (Testicular Cancer) 01/2018 - 07/2012
6	Carcinoma (Carcinomatosis) 01/2017 - 01/2005
5	Inflammation (Inflammations) 01/2020 - 04/2003
5	Breast Neoplasms (Breast Cancer) 01/2019 - 08/2008
4	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2013
4	Melanoma (Melanoma, Malignant) 01/2017 - 01/2002
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 07/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 04/2008
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 03/2013
3	Colitis 03/2015 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014 - 11/2013
2	Schizophrenia (Dementia Praecox) 01/2018 - 01/2017
2	Cognitive Dysfunction 01/2018 - 01/2016
2	Fibrosarcoma 01/2017 - 06/2006
2	Hypoxia (Hypoxemia) 01/2017 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2015 - 05/2011
2	Esophageal Squamous Cell Carcinoma 04/2014 - 07/2012
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2014 - 04/2013
2	Disease Progression 11/2013 - 04/2013
1	Neoplasm Micrometastasis 01/2022
1	Ischemia 01/2021
1	Reperfusion Injury 01/2021
1	Lymphocytosis 12/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2018
1	Leukemia 12/2018
1	Philadelphia Chromosome 12/2018
1	Virus Diseases (Viral Diseases) 05/2018
1	Poliomyelitis (Polio) 01/2018

Drug/Important Bio-Agent (IBA)

19	Peptides (Polypeptides)IBA 01/2022 - 09/2010
18	AntigensIBA 01/2022 - 01/2002
16	CytokinesIBA 01/2020 - 02/2002
15	Monoclonal AntibodiesIBA 01/2022 - 01/2002
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 01/2002
12	LigandsIBA 09/2015 - 01/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
11	EpitopesIBA 01/2018 - 09/2010
10	Protein Subunit VaccinesIBA 01/2022 - 09/2010
9	TNF-Related Apoptosis-Inducing LigandIBA 01/2020 - 02/2002
9	AntibodiesIBA 01/2018 - 01/2002
8	InterferonsIBA 12/2017 - 01/2002
7	VaccinesIBA 01/2022 - 09/2010
7	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2020 - 02/2004
7	alpha-galactosylceramideIBA 08/2008 - 02/2002
5	Cancer VaccinesIBA 01/2022 - 07/2012
5	Messenger RNA (mRNA)IBA 01/2019 - 07/2012
5	Interleukin-12 (IL 12)IBA 12/2017 - 01/2002
5	PerforinIBA 12/2014 - 01/2002
5	HLA-A Antigens (HLA-A)IBA 03/2014 - 10/2012
4	Therapeutic UsesIBA 01/2022 - 01/2005
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
4	Fc Receptors (Fc Receptor)IBA 10/2017 - 02/2004
4	CarcinogensIBA 05/2015 - 01/2002
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2014 - 10/2012
4	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2014 - 07/2012
4	KinesinsIBA 01/2014 - 01/2012
4	Fas Ligand Protein (Fas Ligand)IBA 09/2010 - 02/2002
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2012
3	Interleukin-2 (IL2)IBA 01/2020 - 04/2008
3	Neutralizing AntibodiesIBA 01/2018 - 12/2008
3	MethylcholanthreneIBA 01/2017 - 01/2002
3	Death Domain ReceptorsIBA 02/2016 - 10/2004
3	Carrier Proteins (Binding Protein)IBA 04/2014 - 04/2013
3	Protein Kinases (Protein Kinase)IBA 04/2014 - 07/2012
3	Complementary DNA (cDNA)IBA 09/2010 - 01/2002
3	interleukin-21 (interleukin 21)IBA 04/2008 - 05/2006
2	Karyopherins (Importin)IBA 01/2020 - 12/2011
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2003
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 05/2012
2	Natural Killer Cell ReceptorsIBA 12/2017 - 01/2009
2	Oncogene Proteins (Oncogene Protein)IBA 01/2017 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 12/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 09/2015
2	ChemokinesIBA 09/2015 - 03/2015
2	Dextran SulfateIBA 03/2015 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 03/2015 - 04/2010
2	Gemcitabine FDA Link 01/2014 - 11/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2013 - 03/2013
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 04/2013 - 07/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2013 - 09/2007
2	Interleukin-18 (Interleukin 18)IBA 04/2003 - 02/2002
2	Interferon-gamma (Interferon, gamma)IBA 02/2002 - 01/2002
1	B7-H1 AntigenIBA 01/2022
1	Thymic Stromal LymphopoietinIBA 01/2020
1	atelocollagenIBA 01/2020
1	importazoleIBA 01/2020
1	Carcinoembryonic AntigenIBA 01/2019
1	Cell Adhesion MoleculesIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Chemokine CXCL12IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 12/2018
1	Propolis (Bee Bread)IBA 05/2018

Therapy/Procedure

37	Therapeutics 01/2022 - 11/2002
21	Immunotherapy 01/2021 - 01/2002
13	Drug Therapy (Chemotherapy) 05/2018 - 01/2007
3	Radiotherapy 01/2014 - 01/2007
2	Ligation 05/2015 - 08/2008
1	Liver Transplantation 01/2021